Comparative amplification analysis of human glioma tissue and glioma derived fragment spheroids using reverse chromosome painting (RCP)

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2601-2606

  Janka, Michael ^a   Fischer, Ulrike ^b   Tonn, Jörg Christian ^a   Kerkau, Siglinde ^a   Roosen, Klaus ^a   Meese, Ekkard ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c Univ of Würzburg ^*

Author keywords

DNA amplification; Glioma; Reverse chromosome painting; Tumor fragment spheroids

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 11P; CHROMOSOME 12Q; CHROMOSOME 4Q; CHROMOSOME PAINTING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; FEMALE; GENE AMPLIFICATION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOLAYER CULTURE; PRIORITY JOURNAL; TISSUE CULTURE;

ADULT; AGED; BRAIN NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; SPHEROIDS, CELLULAR;

EID: 0029859257     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bigner SH, Wong AJ, Bigner DD, et al: Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet 29: 165-170, 1987.
2. Weinberg, RA: Tumor suppressor genes. Science 254: 1138-1146, 1991.
3. Seeger RC, Brodeur GM, Hammond D, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111-1116, 1985.
4. Slamon DJ, Clark GM, McGuire WL. et al: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987.
5. Slamon DJ, Godolphin W, Ullrich A, et al: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712, 1989.
6. Bishop JM: Molecular themes in oncogenesis. Cell 64: 235-248, 1991.
7. Lihermann TA, Nussbaum HR, Schlessinger T, et al: Amplification enhanced expression and possible rearrangement of the EGFR gene in primary human brain tumors of glial origin. Nature 313: 144-147, 1985.
8. Collins VP: Amplified genes in human gliomas. Semin Cancer Biol 4: 27-33, 1993.
9. Kinzler KW, Bigner SH, Vogelstein B, et al: Identification of an amplified highly expressed gene in human glioma. Science 236: 70-73, 1987.
10. Reifenberger G, Liu L, Collins VP, et al. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without pS3 mutations. Cancer Res 53: 2736-2739, 1993.
11. Wong AJ, Bigner SH, Vogelstein B, et al: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899-6903, 1987.
12. Wuller GN, Bigner SH: Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res 276(3): 299-306, 1992.
13. Fukumolo M, Shevrin DH, Roninson IB: Analysis of gene amplification in human tumor cell lines. Proc Natl Acad Sci USA 85(18): 6846-50, 1988.
14. Hirotsune S, Hatada I, Mukai T, et al: New approach for detection of amplifications in cancer DNA using restriction landmark genomic scanning. Cancer Res 52: 3642-3647, 1992.
15. Wullich B, Mueller HW, Meese E, et al: Amplified MET gene linked to double minutes in human glioblastoma. Eur J Cancer 29A/14: 1991-1995, 1993.
16. Wullich B, Sattler HP, Meese E, et al: Two independant amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification ofthe oncogene MET. Anticancer Res 14,2A: 577-580, 1994.
17. Fischer U, Wullich B, Meese E: DNA amplifications on chromosomes 7, 9 and 12 in glioblastoma detected by reverse chromosome painting. Eur J Cancer Vol 30A,8: 1124-1127, 1994.
18. Schroeck E, Thiel G, Cremer T, et al: Comparative genomic hybridization of human malignant glioma reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144: 1203-1218, 1994.
19. Bjerkvig R, Tonnesen A, Backlund EO, et al: Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72: 463-475, 1990.
20. Bjerkvig R, Høstmark J, Laerum OD, et al: Tumor spheroids from biopsy specimens. In: Bjerkvig R (ed): Spheroid Culture in Cancer Research, Boca Raton, CRC Press, 1992, pp 41-56.
21. Paulus W, Huettner C, Tonn JC: Collagenes, integrins and mesenchymal drift in gioblastomas: a comparison of biopsy specimens, spheroid and early monolayer cultures. Int J Cancer 58: 841-846, 1994.
22. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning - a laboratory manual. Cold Spring Harbor Laboratory Press 1989.
23. du Manoir S, Speicher MR, Cremer T, et al: Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90: 590-610, 1993.
24. Arakaki DT, Sparkes RS: Microtechnique for culturing leukocytes from whole blood. Cytogenet 2: 57, 1963.
25. Joos S, Scherthan H, Lichter P. et al: Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe. Hum Genet 90(6): 584-589, 1993, 12
26. Gottert E, Klein V, Meese E: Generation of a chromosome 22-specific library as confirmed by FISH analysis. Hum Genet 92: 623-626, 1993.
27. Muleris M, Almeida A, Dutrillaux B, et al: Oncogenc amplification in human gliomas: a molecular cytogenetic analysis. Oncogene 9(9): 2717-2722, 1994.
28. Dalrymple SJ, Jenkins RB: Molecular genetics of astrocytoma and meningioma. Current Opinion in Neurology 7: 477-483, 1994.
29. Collins VP: Cultured human glial and glioma cells. Int Rev Exp Pathol 24: 135-202, 1983.
30. Yung WKA, Shapiro JR, Shapiro WR: Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42: 992-998, 1982.
31. Shapiro JR, Scheck AL: Molecular biological events in the selection of chemotherapy resistent cells in human malignant gliomas. In: Paoletti P, Tahakura K. Walter MD, Butti G, Pezzotta S (Eds): Neuro-Oncology, Kluwer Publ., Dordrecht, 1991, pp 21-26.
32. Steinsvaag SK, Bjerknes R: Spheroids of normal tissue culture. In: Bjerkvig R (ed): Spheroid Culture in Cancer Research, Boca Raton, CRC Press, 1992, pp 19-33.
33. Acker H, Holtermann G, Carlsson J, et al: Influence of glucose on metabolism and growth of rat glioma cells (c6) in multicellular spheroid culture. Int J Cancer 52: 279-285, 1992.
34. Kotitschke K, Tonn JC, Haase A, et al: 1H NMR investigations of tumor spheroids grown from a human glioma biopsy or from a human malignant glioma cell line. J Magnetic Resonance, Series B 109: 39-43, 1995.
35. Collins VP, James CD: Gene and chromosomal alterations associated with the development of human gliomas. FASEB J 7: 926-930, 1993.
36. Mikkelsen T: Genetics of astrocytic tumor progression. Mol Genet Med 3: 69-94, 1993.
37. Dalrymple SJ, Herath JF, Jenkins RB, et al: Correlation of cytogenetic and fluorescence in situ hybridization (FISH) studies in normal and gliotic brain. J Neuropathol Exp Neurol 53(5): 448-456, 1994.
38. Shapiro JR, Scheck AC, Fiola MR, et al: Tumor heterogenity and intrinsically chemoresistant subpopulations in freshly resected human malignant gliomas. Basic Life Sci 57: 243-261, 1991.
39. Yung WK, Shapiro JR, Shapiro WR: Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42(3): 992-998, 1982.